Ana Balske

Prevention of Bone Loss with Alendronate in Postmenopausal Women under 60 Years of Age

David Hosking, Clair E.D. Chilvers, Claus Christiansen et al. · New England Journal of Medicine · 1998 · 487 citations · Full text

The Efficacy and Tolerability of Risedronate Once a week for the Treatment of Postmenopausal Osteoporosis

Jacques P. Brown, David L. Kendler, Michael R. McClung et al. · Calcified Tissue International · 2002 · 334 citations

Bone Disease, Bone Health, Risedronate Once +6

Prevention of Bone Loss With Alendronate in Postmenopausal Women Under 60 Years of Age

David Hosking, Clair Chilvers, Claus Christiansen et al. · Obstetrical & Gynecological Survey · 1998 · 211 citations

Literary Theory, Clair E. D., Gynecology +17

Alendronate and Estrogen–Progestin in the Long-Term Prevention of Bone Loss: Four-Year Results from the Early Postmenopausal Intervention Cohort Study: A Randomized, Controlled Trial

Pernille Ravn, Marianne Bidstrup, Richard D. Wasnich et al. · Annals of Internal Medicine · 1999 · 186 citations

Treatment of postmenopausal osteoporosis with delayed-release risedronate 35 mg weekly for 2 years

Michael R. McClung, Ana Balske, David E. Burgio et al. · Osteoporosis International · 2012 · 47 citations · Full text